ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · Q · methodology v0.1 · reviewer not yet appointed
Compound index · Q ETA-DOC-0004

Compound index — Q

76 substances begin with Q. 0 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 76 of them, Q10 (Coenzyme Q… – Quizartinib Dihydrochlorid….

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Q10 (Coenzyme Q, Ubiquinione) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Q10 is a component in the formation of energy Q10 contribute to the formation of energy in cells”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012213
Q10 with Sea Buckthorn Oil, Q 10, Hippophae oleum, Q 10 , Hippophae oleum EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Vitaminising / Has antioxidant properties and helps protect you from radicals which cause cell damage / Physical endurance, mental performance / Helps to protect heart health / Supports digestive and hepatic health/ Immune system health / Contributes to the resistance against stress.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012214
Quahog, Unspecified US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012215
Quassia amara CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012216
Quassia Amara Wood US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012217
Quazepam US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: bulk ingredient
Class as recordedBenzodiazepine [EPC]; Benzodiazepines [CS]; DEA: depressant
Earliest US approval1985
Market presence2 US product listings · 1 FDA applications
DEA other namesDoral
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-012218
Quebracho CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012219
Quebracho Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012220
Quercetin CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 3 refusedCA licensed ingredientUS: bulk ingredient
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Amino Acids
Market presence25 US product listings · 65 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“For cardiovascular health”Non-authorisedArt.13(1)EFSA opinion
“For the health of the nervous system and the brain”Non-authorisedArt.13(1)EFSA opinion
“Quercetin containing foods contribute to keep your body healthy Antioxidant containing foods support of healthy ageing Antioxidants contribute to the total antioxidant capacity of the body and may help strengthen our body´s defences”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-012221
Quercetin-3-O-glucoside CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012222
Quercetin-3-rutinoside CA-NHP Not yet graded
CA licensed ingredient
Market presence79 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012223
Quercetin-zein EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012224
Quercetine EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“For liver and kidney health.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012225
Quercitrin CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012226
Quercus Acutissima Whole US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012227
Quercus Agrifolia Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence13 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012228
Quercus Agrifolia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012229
Quercus alba CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012230
Quercus Alba Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAntimalarial [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012231
Quercus Alba Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence54 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012232
Quercus Alba Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012233
Quercus Alba Wood US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedIncreased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012234
Quercus cortex EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Oak Bark; Quercus robur L.L.;Quercus petraea (Matt.) Liebl.;Quercus pubescens Willd.
Class as recordedherbal: Skin disorders and minor wounds;Circulatory disorders;Gastro
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-012235
Quercus Dumosa Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012236
Quercus Gambelii Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012237
Quercus Garryana Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012238
Quercus Garryana Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012239
Quercus glandium spiritus CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012240
Quercus Kelloggii Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence13 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012241
Quercus Kelloggii Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012242
Quercus Lobata Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012243
Quercus Macrocarpa Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence18 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012244
Quercus Marilandica Pollen US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012245
Quercus Nigra Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012246
Quercus pedunculata CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012247
Quercus pedunculata-Buds-Oak EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Normal immune system function.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012248
Quercus robur CA-NHP Not yet graded
CA licensed ingredient
Market presence56 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012249
Quercus Robur Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012251
Quercus Robur Flower BUD US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Ascorbic Acid [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012252
Quercus robur L. EU-NOVEL Not yet graded
Not novel in supplements
Parts in scopeWhole (bark,fruit, nut gal, leaf, bud, seeds and wood)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012250
Quercus Robur NUT US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012253
Quercus Robur Pollen US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012254
Quercus Robur Twig Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012255
Quercus Robur Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012256
Quercus Robur Wood US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012257
Quercus robur-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012258
Quercus rotundifolia Lam. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruit (acorn)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012259
Quercus Rubra Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antigens
Market presence77 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012260
Quercus Rubra Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012261
Quercus Spp. Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012262
Quercus Stellata Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012263
Quercus Velutina Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012264
Quercus Velutina Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012265
Quercus Virginiana Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence31 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012266
Quetiapine US-DRUG Not yet graded
US: anda
Class as recordedAtypical Antipsychotic [EPC]
Earliest US approval1997
Market presence417 US product listings · 41 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012267
Quillaja saponaria CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012268
Quillaja Saponaria Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012269
Quillaja Saponaria Wood US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012270
Quillaya saponaria CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012271
Quinacrine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012272
Quinapril Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]
Earliest US approval1991
Market presence56 US product listings · 21 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012273
Quince US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012274
Quinestrol US-DRUG Not yet graded
Earliest US approval1996
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012275
Quinethazone US-DRUG Not yet graded
Earliest US approval1963
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012276
Quinhydrone US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012277
Quinic Acid US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012278
quinidine EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: anda
Class as recordedAntiarrhythmic [EPC]; Cytochrome P450 2D6 Inhibitor [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; N07XX59
Earliest US approval1950
Market presence16 US product listings · 69 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-012279
Quinidine Polygalacturonate US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012280
Quinine CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adrenergic alpha-Agonists [MoA]
Earliest US approval2005
Market presence72 US product listings · 6 FDA applications · 3 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-012281
Quinine Arsenate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antimalarial [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012282
Quinine Arsenite US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence21 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012283
Quinoa (Chenopodium quinoa) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Stimulation of the hair bulb, favouring the growth of the hair”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012284
Quinone US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012285
Quinupristin US-DRUG Not yet graded
Earliest US approval1999
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012286
Quisqualis Indica Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012287
Quizartinib Dihydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, RefusedUS: drug for further processing
Class as recordedFMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]; Kinase Inhibitor [EPC]; L01EX11; L01XE
Earliest US approval2023
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-012288